Acceler8 Ventures PLC
15 July 2026
15 July 2026
ACCELER8 VENTURES PLC
Publication of Prospectus
Further to the announcement on 13 July 2026 regarding the notice of a general meeting, the Board of Acceler8 Ventures Plc (LSE: AC8, "AC8" or the "Company"), is pleased to announce that a prospectus (the "Prospectus") has been approved by the Financial Conduct Authority and published today.
The Prospectus relates to: (i) the proposed acquisition of IIG and (ii) the proposed admission of the Ordinary Shares in the Company to the Equity Shares (Commercial Companies) category of the Official List and to trading on the London Stock Exchange's Main Market for listed securities ("Admission").
A copy of the Prospectus has been submitted to the National Storage Mechanism and will shortly be available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism. The Prospectus is also available for inspection on the Company's website at: https://acceler8.ventures/.
The Company also announces that it has today entered into a lock-in deed with Malcolm Le May in relation to the Ordinary Shares in the Company that he will hold or be issued at Admission or that he acquires during the Lock-in Period (as defined in the lock-in deed). The lock-in deed is conditional upon Admission. A copy of the lock-in deed has been uploaded to the Company's website at https://acceler8.ventures.
Enquiries:
|
Acceler8 Ventures Plc |
David Williams |
C/o Tessera Investment Management Limited |
|
Tessera Investment Management Limited (Financial Adviser to AC8) |
Tony Morris |
Tel: 07742 189145 |
|
Joh. Berenberg, Gossler & Co. KG, London Branch (Sponsor, Rule 3 Adviser and Financial Adviser to AC8) |
Matthew Armitt Miles Cox Mark Whitmore Alex Wright |
Tel: 020 3207 7800 |
Important notice
Terms used but not defined in this announcement have the meaning set out in the Prospectus.
This announcement does not constitute a prospectus or a prospectus equivalent document.
This announcement is for information purposes only and does not constitute, and may not be construed as, an offer to sell or an invitation or recommendation to purchase, sell or subscribe for any securities or investments of any description, or a recommendation regarding the issue or the provision of investment advice by any party. The information contained in this announcement is given at the date of its publication (unless otherwise marked).
The release, publication or distribution of this announcement (in whole or in part) in, into or from jurisdictions other than the United Kingdom may be restricted by the laws of those jurisdictions and therefore persons into whose possession this Document and any accompanying documents come should inform themselves about and observe any such restrictions and applicable requirements. Any failure to comply with those restrictions or requirements may constitute a violation of the securities laws of any such jurisdiction.
The Ordinary Shares, including the New Ordinary Shares have not been, and will not be, registered with the SEC under the US Securities Act or under the securities laws of any state or other jurisdiction of the United States. Accordingly, the Ordinary Shares, including the New Ordinary Shares may not be offered, sold, resold, delivered, distributed or otherwise transferred, directly or indirectly, in or into or from the United States absent registration under the US Securities Act or an exemption therefrom. The New Ordinary Shares are expected to be issued in reliance upon the exemption from the registration requirements of the US Securities Act provided by Section 3(a)(10) thereof.
Joh. Berenberg, Gossler & Co. KG, London Branch ("Berenberg") has been appointed as Sponsor, Rule 3 Adviser and Financial Adviser to AC8 in connection with the Admission and Acquisition. Berenberg is authorised and regulated in Germany by the German Federal Financial Supervisory Authority and subject to limited regulation in the United Kingdom by the FCA. Berenberg is acting exclusively for the Company and no one else in connection with Admission, the Acquisition or any other transaction, matter or arrangement referred to in this announcement. The Sponsor will not regard any other person (whether or not a recipient of this announcement) as its client in relation to Admission, the Acquisition or any other transaction, matter or arrangement referred to in this announcement and will not be responsible to anyone other than the Company for providing the protections afforded to their respective clients or for providing any advice in relation to Admission, the Acquisition or any other transaction, matter or arrangement referred to in this announcement.
Tessera Investment Management Limited ("Tessera"), is acting exclusively as financial adviser to AC8 and no one else in connection with the Acquisition and other matters described in this announcement and will not be responsible to anyone other than AC8 for providing the protections afforded to clients of Tessera or for providing advice in connection with the Acquisition or any other matter referred to herein. Neither Tessera nor any of its affiliates (nor their respective directors, officers, employees or agents) owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person who is not a client of Tessera in connection with this announcement, any statement contained herein or otherwise.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
ENDRNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.